Evidence map›Paper›PMID 17046175›Full record

ArticleGene2007

EP4 receptor regulates collagen type-I, MMP-1, and MMP-3 gene expression in human tendon fibroblasts in response to IL-1 beta treatment.

Bhavani P Thampatty, Hongxia Li, Hee-Jeong Im, James H-C Wang

Open access · greenAbstract read
In one paragraph

Article in Gene, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 105 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Prolyl-Hydroxyproline Promotes Structural Matrix Organization in 3D Equine Tendon Proper and Peritenon Post-Injury Model.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. [Clinical characteristics of crystal deposits in joints and tendons in patients with gout].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2021
    Article
  17. Tendon healing is adversely affected by low-grade inflammation.Journal of orthopaedic surgery and research · 2021
    Review
  18. [Tendinopathies of the Achilles tendon].Zeitschrift fur Rheumatologie · 2021
    Article
  19. Article
  20. Bone Marrow Aspirate Matrix: A Convenient Ally in Regenerative Medicine.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Bhavani P ThampattyMechanoBiology Laboratory, Departments of Orthopaedic Surgery and Bioengineering, University of Pittsburgh, E1640 Biomedical Science Tower, 210 Lothrop Street, Pittsburgh, PA 15213, USA.
Hongxia Li
Hee-Jeong Im
James H-C Wang
University of Pittsburgh · USRush University Medical Center · US

Funding

Defining the role of tendon stem cells in the development of tendinopathyR01AR049921 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WANG, JAMES H-C. · 2002 to 2010
$2.8M
Pathological Role of bFGF in Human Adult Articular CartilageR01AR053220 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI SAMPEN, HEE-JEONG IM · 2006 to 2010
$1.6M
OSTEOARTHRITIS AND KNEE JOINT PAINI01BX002647 · VA · JESSE BROWN VA MEDICAL CENTER · PI SAMPEN, HEE-JEONG IM · 2015 to 2023
–
BLRD VA I01 BX002647NIAMS NIH HHS AR049921NIAMS NIH HHS R01 AR049921NIAMS NIH HHS R01 AR053220
6 · The paper itself

Abstract

Tendinopathy is accompanied by inflammation, tendon matrix degradation, or both. Inflammatory cytokine IL-1beta, which is a potent inflammatory mediator, is likely present within the tendon. The purpose of this study was to determine the biological impact of IL-1beta on tendon fibroblasts by assessing the expression of cPLA(2), COX-2, PGE(2) and its receptors (EPs), collagen type-I, and MMPs. We also studied the role of the p38 MAPK pathway in IL-1beta-induced catabolic effects. We found that IL-1beta increased the expression levels of cPLA(2) and COX-2, and also increased the secretion of PGE(2). Induction of MMPs, such as MMP-1 and MMP-3 at the mRNA level, was also observed after stimulation with IL-1beta. Furthermore, the presence of IL-1beta significantly decreased the level of collagen type-I mRNA in tendon fibroblasts. These effects were found to be mediated by selective upregulation of EP(4) receptor, which is a member of G-protein-coupled receptor that transduces the PGE(2) signal. Blocking EP(4) receptor by a specific chemical inhibitor abolished IL-1beta-induced catabolic effects. These results suggest that IL-1beta-induced catabolic action on tendon fibroblasts occurs via the upregulation of two key inflammatory mediators, cPLA(2) and COX-2, which are responsible for the synthesis of PGE(2). IL-1beta further stimulates the expression of EP(4) receptor, suggesting positive feedback regulation which may lead to accelerated catabolic processes in tendon fibroblasts. Studies using pathway-specific chemical inhibitors suggest that the p38 MAPK pathway is the key signaling cascade transducing IL-1beta-mediated catabolic effects. Collectively, our findings suggest that the EP(4) receptor mediates the IL-1beta-induced catabolic metabolism via the p38 MAPK pathway in human tendon fibroblasts and may play a major role in the tendon's degenerative changes often seen in the later stages of tendinopathy.

Indexed as

Cells, CulturedCollagen Type ICyclooxygenase 2FibroblastsGene Expression RegulationHumansInterleukin-1betaMaleMAP Kinase Signaling SystemMatrix Metalloproteinase 1Matrix Metalloproteinase 3Membrane Proteinsp38 Mitogen-Activated Protein KinasesPhospholipases AReceptors, Prostaglandin EReceptors, Prostaglandin E, EP4 SubtypeCollagen Type ICyclooxygenase 2Interleukin-1betaMatrix Metalloproteinase 1Matrix Metalloproteinase 3Membrane Proteinsp38 Mitogen-Activated Protein KinasesPhospholipases APTGER4 protein, humanPTGS2 protein, humanReceptors, Prostaglandin EReceptors, Prostaglandin E, EP4 Subtype

Identifiers

PMID17046175
PMCPMC1839868
OpenAlexW2008414056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.